Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.

Warrell, R P

Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma. [electronic resource] - Cancer treatment reports - 1157-8 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0361-5960


Adult
Aged
Aminoacridines--adverse effects
Amsacrine
Antineoplastic Agents--adverse effects
Drug Evaluation
Humans
Lymphoma--drug therapy
Middle Aged